{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:21:50Z","timestamp":1751430110238,"version":"3.41.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007586","name":"Aix-Marseille Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.rpth.2025.102721","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T16:36:25Z","timestamp":1741019785000},"page":"102721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A rare case of factor X deficiency induced by valproic acid"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7775-5157","authenticated-orcid":false,"given":"Pierre-Antonin","family":"Rigon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Ernest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.102721_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11239-021-02456-w","article-title":"Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics","volume":"52","author":"Camire","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2025.102721_bib2","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-2516.2008.01856.x","article-title":"Diagnosis and treatment of inherited factor X deficiency","volume":"14","author":"Brown","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2025.102721_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1365-2516.2002.00633.x","article-title":"Rare coagulation deficiencies","volume":"8","author":"Peyvandi","year":"2002","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2025.102721_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.21603","article-title":"Systemic AL amyloidosis with acquired factor X deficiency: a study of perioperative bleeding risk and treatment outcomes in 60 patients","volume":"85","author":"Thompson","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.102721_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/a-1496-8527","article-title":"Autoimmune coagulation factor X deficiency as a rare acquired hemorrhagic disorder: a literature review","volume":"122","author":"Ichinose","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102721_bib6","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/hae.14798","article-title":"Clinical features and laboratory diagnostic issues of non-immune, non-amyloid related acquired factor X deficiency","volume":"29","author":"Ichinose","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2025.102721_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2516.2012.02773.x","article-title":"Acquired, non-amyloid related factor X deficiency: review of the literature","volume":"18","author":"Lee","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2025.102721_bib8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.burns.2007.06.009","article-title":"Transient selective factor X deficiency in a severely burned child","volume":"34","author":"Jennes","year":"2008","journal-title":"Burns"},{"key":"10.1016\/j.rpth.2025.102721_bib9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1600-0609.1996.tb01387.x","article-title":"Acquired and transient factor X deficiency associated with sodium valproate treatment","volume":"57","author":"Gallais","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2025.102721_bib10","first-page":"435","article-title":"[Pharmacodynamic properties of N-dipropylacetic acid]","volume":"18","author":"Meunier","year":"1963","journal-title":"Therapie"},{"year":"2022","series-title":"Epilepsies in children, young people and adults","key":"10.1016\/j.rpth.2025.102721_bib11"},{"key":"10.1016\/j.rpth.2025.102721_bib12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.rpth.2025.102721_bib13","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.rpth.2025.102721_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.pcl.2013.09.002","article-title":"Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond","volume":"60","author":"Kumar","year":"2013","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.rpth.2025.102721_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2019.04.019","article-title":"Valproic acid-induced coagulopathy","volume":"98","author":"Kumar","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.rpth.2025.102721_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264351","article-title":"Assessment of need for hemostatic evaluation in patients taking valproic acid: a retrospective cross-sectional study","volume":"17","author":"Post","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.rpth.2025.102721_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/088307389400900318","article-title":"Thrombocytopenia secondary to high valproate levels in children with epilepsy","volume":"9","author":"Delgado","year":"1994","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.rpth.2025.102721_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","article-title":"Valproate-induced thrombocytopenia: a prospective monotherapy study","volume":"49","author":"Nasreddine","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.rpth.2025.102721_bib19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1528-1167.2006.00587.x","article-title":"Valproate-associated coagulopathies are frequent and variable in children","volume":"47","author":"Gerstner","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.rpth.2025.102721_bib20","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/ped.13056","article-title":"Hypofibrinogenemia and intra-articular hemorrhage due to valproic acid","volume":"58","author":"Karakayal\u0131","year":"2016","journal-title":"Pediatr Int"},{"key":"10.1016\/j.rpth.2025.102721_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.0013-9580.2004.28302.x","article-title":"Factor XIII deficiency associated with valproate treatment","volume":"45","author":"Teich","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.rpth.2025.102721_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0037-1617026","article-title":"Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare","volume":"29","author":"Eberl","year":"2009","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.rpth.2025.102721_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1442-200X.2008.02604.x","article-title":"Factor VII deficiency associated with valproate treatment","volume":"50","author":"Unalp","year":"2008","journal-title":"Pediatr Int"},{"key":"10.1016\/j.rpth.2025.102721_bib24","article-title":"Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency","volume":"50","author":"Peyvandi","year":"2021","journal-title":"Blood\u00a0Rev"},{"key":"10.1016\/j.rpth.2025.102721_bib25","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/hae.14852","article-title":"Factor X inhibitors: a seldom seen but important antibody mediated process","volume":"29","author":"Gollard","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2025.102721_bib26","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/j.1528-1167.2010.02788.x","article-title":"Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study","volume":"51","author":"Sahaya","year":"2010","journal-title":"Epilepsia"},{"issue":"suppl S7","key":"10.1016\/j.rpth.2025.102721_bib27","first-page":"118","article-title":"Levetiracetam might induce or aggravate von Willebrand disease: a case report [abstract]","volume":"44","author":"Baier","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.rpth.2025.102721_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/hae.14692","article-title":"Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database","volume":"29","author":"Konstantinov","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2025.102721_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.23736\/S0031-0808.23.05023-1","article-title":"Acquired hemophilia A induced by clopidogrel","volume":"66","author":"Liu","year":"2024","journal-title":"Panminerva Med"},{"key":"10.1016\/j.rpth.2025.102721_bib30","article-title":"Calcium channel blocker-induced thrombocytopenia in the intensive care unit: a rare presentation and review of the literature","volume":"15","author":"Zhou","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.rpth.2025.102721_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.0042-9007.2004.00376.x","article-title":"Amlodipine-induced immune thrombocytopenia","volume":"86","author":"Garbe","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.rpth.2025.102721_bib32","article-title":"Atorvastatin-induced refractory thrombocytopenia","volume":"13","author":"Ghuman","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.rpth.2025.102721_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2024.2437768","article-title":"Alterations in platelet activity and endothelial glycocalyx biomarkers by treatment with an angiotensin converting enzyme inhibitor or an alpha-1 adrenoceptor antagonist in patients with hypertension: results from the DoRa study","volume":"35","author":"Ekholm","year":"2024","journal-title":"Platelets"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:51:15Z","timestamp":1751399475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2475037925000457"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102721","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rare case of factor X deficiency induced by valproic acid","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102721"}}